NCT07467356 Anterior Iliopsoas Space Block Versus PENG Block on Ease of Positioning for Spinal Anathesia in Patients Undergoing Hip Surgeries
| NCT ID | NCT07467356 |
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | Benha University |
| Condition | Pain Management |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2026-03-15 |
| Primary Completion | 2026-08-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 3 trials are large pivotal studies comparing the treatment to current standard of care or placebo. Your participation directly contributes to the evidence needed for regulatory approval.
This trial targets 90 participants in total. It began in 2026-03-15 with a primary completion date of 2026-08-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Total hip arthroplasty (THA) has been one of the most significant advancements in orthopedic surgery over the past century. hip fractures are typically associated with severe pain, effective analgesia is crucial both before and after surgery.Spinal anesthesia (SA) is the most commonly employed method of anesthesia for repairing these fractures.The anterior iliopsoas space block is a considered as a novel technique that targets the lumbosacral trunk as it passes beneath the psoas major muscle, offering potential advantages over the traditional sacral plexus block, which is performed in the supine position.
Eligibility Criteria
Inclusion Criteria: * (ASA )classes I and II * patients of either sex, above the age of 18 who will undergo hip surgeries( (Dynamic hip screw fixation or hemiarthroplasty)(not older than 2 weeks) with persistent pain and scheduled for surgery under SA with an expected duration of 2.5 hours Exclusion Criteria: * patient's refusal to participate * any contraindications to SA or peripheral nerve blocks * history of ischemic heart disease * patients on opioids for chronic pain * patients with significant cognitive impairment.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07467356 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pain Management. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07467356 trial and what does that mean for participants?
Phase 3 trials are large-scale studies comparing the new treatment to existing standards of care or a placebo. They provide the evidence needed for regulatory approval. This trial targets 90 participants.
Is NCT07467356 currently recruiting?
Yes, NCT07467356 is actively recruiting participants. Contact the research team at drfatmaahmed86@gmail.com for enrollment information.
Where is the NCT07467356 trial being conducted?
This trial is being conducted at Banhā, Egypt.
Who is sponsoring the NCT07467356 clinical trial?
NCT07467356 is sponsored by Benha University. The trial plans to enroll 90 participants.